Picture a phone ringing in a Norfolk kitchen. The caller is a member of a central support team who has already reviewed the patient's record and knows they qualify for help with their weight. The patient never asked for it and, under the usual arrangements, might never have done so. That call is the mechanism behind one of the more striking prevention results in the NHS this year. Norfolk and Suffolk Integrated Care Board reported 4,458 referrals into its digital weight management programme during 2025/26, some 187% of its target. Data integration tools scanned practice records to find eligible people, and a central team contacted them directly. Ninety-two per cent of general practices took part, and 94% of referrals were judged accurate. In a health service more used to missing targets than doubling them, the figures deserve attention.

The reason they matter goes beyond one programme. The government's health mission depends on moving care from hospitals to communities and from treatment to prevention, and that ambition has repeatedly foundered on a practical question: who finds the patients? General practice cannot absorb another proactive task when appointments are already scarce and morale is fragile. Norfolk and Suffolk removed the task from practices and gave it to a dedicated function fed by shared data. That is a specific and replicable answer, and it arrives at a useful moment.

The phased NHS rollout of tirzepatide will draw on a very large eligible population, far bigger than local services can treat at once. Systems that can identify and prioritise eligible patients will distribute access more fairly than those that wait for patients to present, since people who book appointments easily tend to be the ones already best served. Proactive outreach reaches those who do not, and they are disproportionately poorer and sicker. It also offers integrated care boards something they need. With running costs under pressure and national structures being redrawn, ICBs must show that they perform functions no single provider can. Population-level identification and outreach is a credible candidate.

Caution is warranted all the same. A referral is a starting point, and the reported figures say nothing yet about weight lost, health gained or demand avoided. A target of 187% can also reflect a modest original target. Digital programmes suit some patients and exclude others, and people contacted about their health by a team they have never met may reasonably ask how their records were used. Trust will depend on transparent governance, and leaders who treat that as an afterthought risk a backlash that damages the whole approach.

The wider regional picture adds a warning. Health checks for people with serious mental illness reached 65% coverage, which is a respectable result. Breast screening and annual checks for people with learning disabilities lagged, and these are groups where inequality is sharpest and where proactive identification should matter most. The same data tools evidently have not been applied evenly. Neighbourhood health hubs vary in maturity across the region, which limits how uniformly any successful model can be delivered. Elsewhere, community trusts in London, the Liverpool hospital group and the Derbyshire, Lincolnshire and Nottinghamshire cluster have published strategies built around population health data and preventative care, some running to 2031. The language is converging faster than the delivery.

For NHS leaders, the practical lesson is to fund the outreach function as permanent infrastructure and to measure outcomes with the same energy spent counting referrals. Policymakers should expect health-tech suppliers to be asked for evidence of results, and suppliers should prepare accordingly. Prevention works where someone is paid to pick up the phone and has good data in front of them. The test for Norfolk and Suffolk, and for every system copying it, is whether that post survives the next financial squeeze.

‍